What is Fenoterol?
Fenoterol is a Beta 2 adrenergic agonist designed to open up the airways to the lungs. It is classed as sympathomimetic beta2 agonist and asthma medication.
Fenoterol is produced and sold by Boehringer Ingelheim as Berotec N and in combination with ipratropium as Berodual N.
Fenoterol is a short-acting beta2-agonist, which also stimulates beta1 receptors at doses above the recommended therapeutic doses. It was widely used in New Zealand in the early 1990s but withdrawn from that market because of its association with an excess number of deaths.